AAU logo

Medical biotechnology

  • +

    Medical BIotechnology

    Medical biotechnology is an application of biotechnology that improves the lives of individuals every day. In the medical biotechnology research group, we use state-of-the-art technologies to obtain knowledge applicable in the development of better diagnostics and therapeutics. In addition, we seek knowledge of fundamental biological systems, allowing a better differentiation between disease and normal human development and health.

    Focus areas:

    • Ageing and age related diseases
    • Cancer and circulating tumor cells
    • Cardiovascular and heart diseases
    • Probiotics and microbiota
    • Antibody technology
    • Proteases and disease
    • Pathological calcium signaling
    • Bioactive peptides and secondary metabolites
    • Metabolomics
    • Novel lead compounds for drug development

    Vision

    Our research is driven by the ambition of applying science to understand, prevent and treat human diseases.

    Collaborations

    Within the area of medical biotechnology we collaborate broadly with local and national institutions and experts. These include, but are not limited to, researchers from Faculty of Medicine, AAU and Aalborg University Hospital, Copenhagen University, Herlev Hospital, Danish Technical University, and Aarhus University. Internationally we collaborate with researchers all over the world including Japan, China, Australia, Europe and US.

     

Geroscience

Ageing and age related diseases, probiotics and microbiota, proteomics and metabolomics, stress responses and apoptosis and molecular motors

Read more

Molecular engineering

C.elegans Lab

Cancer and circulating tumor cells, ageing and age related diseases, antibody technology and molecular engineering.

read more

Natural Products Chemistry

Cancer, type 2 diabetes and inflammatory diseases, drugs and lead compounds of natural origin, mechanisms of action, pharmacokinetics, large-scale isolation.

Read more

NMR

Biological NMR spectroscopy, cardiovascular and heart diseases, bioactive peptides and secondary metabolites, metabolomics and protein-ligand interactions.

Read more

Protein Science

Cardiovascular and heart disease, brown Bear as a translational model, proteases and disease, valorization of industrial protein side streams.

Read more
 

Medical microbiology


Biofilm, diagnosis, treatment and prevention of infection, in vitro and ex vivo models, and health care data.

Read more

  • +

    Facilities

    To be updated

  • +

    Business partnerships

    A selection of our business partners: 

    • DuPont
    • Novo Nordisk
    • MedImmune
    • BioY

We are aligned with the following UN Sustainable Development Goals.